London-based Fertifa has acquired Juniper Reproductive Health, combining reproductive health benefits and insurance services under one platform. The acquisition brings together Fertifa’s clinical benefits platform with Juniper’s specialized reproductive health insurance coverage.
Juniper was founded in July 2023 by Ambra Zhang and Max Bacon to address gaps in private medical insurance for reproductive health coverage. The company raised venture capital and established partnerships with brokers and early clients before the acquisition.
The combined entity will offer employers access to services including fertility support, menopause care, PCOS and endometriosis treatment, men’s reproductive health, and neurodiversity benefits through a single platform.
“We are excited to welcome Juniper into the Fertifa family,” said Eileen Burbidge, Executive Director of Fertifa. “Juniper’s vision for solving the critical need for reproductive healthcare is perfectly aligned with our own. This acquisition is a significant step forward in our mission to dismantle barriers to care.”
Fertifa provides reproductive health and neurodiversity benefits through its digital platform, offering clinical support including diagnostics, financing, and benefits across fertility, women’s health, men’s reproductive health, and neurodiversity services.
“Joining Fertifa ensures that Juniper’s vision can go further, faster,” said Ambra Zhang, Co-Founder of Juniper. “We built Juniper to prove that reproductive health isn’t niche — it’s fundamental. Combining efforts with Fertifa allows our founding mission to scale rapidly and be integrated into a platform that already offers a comprehensive suite of clinical and family benefits.”
The acquisition expands Fertifa’s client network and strengthens its position in the European reproductive health benefits market. Juniper focused on providing comprehensive reproductive health coverage through pre-vetted clinical networks under membership-based access.
Financial terms of the acquisition were not disclosed.
